Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis

被引:593
作者
Yarlagadda, Sri G. [4 ]
Coca, Steven G. [1 ,2 ,5 ]
Formica, Richard N., Jr. [1 ,2 ,5 ]
Poggio, Emilio D. [3 ]
Parikh, Chirag R. [1 ,2 ,5 ]
机构
[1] Yale Univ, Nephrol Sect, Sch Med, West Haven, CT 06516 USA
[2] Yale Univ, Sch Med, Clin Epidemiol Res Ctr, West Haven, CT 06516 USA
[3] Cleveland Clin, Dept Hypertens & Nephrol, Cleveland, OH 44106 USA
[4] Univ Kansas, Med Ctr, Nephrol Sect, Kansas City, KS 66103 USA
[5] VAMC, New Haven, CT USA
关键词
acute rejection; acute tubular necrosis; graft dysfunction; renal function; serum creatinine; RENAL-FUNCTION; RISK-FACTORS; DONOR AGE; IMPACT; REJECTION; RECIPIENTS; KIDNEYS; SLOW; IMMUNOSUPPRESSION; TRANSPLANTATION;
D O I
10.1093/ndt/gfn667
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Delayed graft function (DGF) is a common complication of renal transplantation. The short-term consequences of DGF are well known, but the long-term relationship between DGF and patient and graft survival is controversial in the published literature. We conducted a systematic review and meta-analysis to precisely estimate these relationships. Methods. We performed a literature search for original studies published through March 2007 pertaining to long-term (> 6 months) outcomes of DGF. The primary outcome was graft survival. Secondary outcomes were patient survival, acute rejection and kidney function. Results. When compared to patients without DGF, patients with DGF had a 41% increased risk of graft loss (RR 1.41, 95% CI 1.27-1.56) at 3.2 years of follow-up. There was no significant relationship between DGF and patient survival at 5 years (RR 1.14, 95% CI 0.94-1.39). The mean creatinine in the non-DGF group was 1.6 mg/dl. Patients with DGF had a higher mean serum creatinine (0.66 mg/dl, 95% CI 0.57-0.74) compared to patients without DGF at 3.5 years of follow-up. DGF was associated with a 38% relative increase in the risk of acute rejection (RR 1.38, 95% CI 1.29-1.47). Conclusion. The results of this meta-analysis emphasize and quantify the long-term detrimental association between DGF and important graft outcomes like graft survival, acute rejection and renal function. Efforts to prevent and treat DGF should be aggressively investigated in order to improve graft survival given the deficit in the number of kidney donors.
引用
收藏
页码:1039 / 1047
页数:9
相关论文
共 52 条
[11]  
COLE E, 1995, CLIN TRANSPLANT, V9, P282
[12]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[13]   Hypertension is an independent predictor of delayed graft function and worse renal function only in kidneys with chronic pathological lesions [J].
Di Paolo, S ;
Stallone, G ;
Schena, A ;
Infante, B ;
Gesualdo, L ;
Schena, FP .
TRANSPLANTATION, 2002, 73 (04) :623-627
[14]   Renal transplants with delayed graft function show decreased renal function despite monitoring with postabsorptive levels [J].
Dominguez, J ;
Gonzalez, A ;
Crossley, N ;
Norambuena, R .
TRANSPLANTATION PROCEEDINGS, 2004, 36 (06) :1655-1658
[15]   Outcome of grafts with long-lasting delayed function after renal transplantation [J].
Fontan, MP ;
RodriguezCarmona, A ;
Bouza, P ;
Falcon, TG ;
Moncalian, J ;
Oliver, J ;
Valdes, F .
TRANSPLANTATION, 1996, 62 (01) :42-47
[16]   Impact of delayed graft function on cadaveric kidney transplant outcome [J].
Gentil, MA ;
Alcaide, MP ;
Algarra, GR ;
Pereira, P ;
Toro, J ;
González-Roncero, F ;
López, M ;
Bernal, G ;
Mateos, J .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) :689-691
[17]   Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys [J].
Giral-Classe, M ;
Hourmant, M ;
Cantarovich, D ;
Dantal, J ;
Blancho, G ;
Daguin, P ;
Ancelet, D ;
Soulillou, JP .
KIDNEY INTERNATIONAL, 1998, 54 (03) :972-978
[18]   Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody [J].
Gonwa, TA ;
Mai, ML ;
Melton, LB ;
Smith, D ;
Levy, MF ;
Goldstein, RM ;
Klintmalam, GB .
CLINICAL TRANSPLANTATION, 2002, 16 (02) :144-149
[19]   Evaluation of the quality of prognosis studies in systematic reviews [J].
Hayden, JA ;
Côté, P ;
Bombardier, C .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (06) :427-437
[20]   Measuring inconsistency in meta-analyses [J].
Higgins, JPT ;
Thompson, SG ;
Deeks, JJ ;
Altman, DG .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7414) :557-560